enGene Therapeutics files Form 3 for SVP Finance, Treasurer Kathleen P. Richton
ENGN•Form 3 filing for Kathleen P. Richton
- enGene Therapeutics named SVP Finance, Treasurer Kathleen P. Richton as a holder of 6,900 common shares, mostly via stock options for 163,900 shares.
